Skip to Main Content

Paper Details

A Phase Ib, Open-label Study Evaluating the Safety and Efficacy of Ipatasertib plus Rucaparib in Patients with Metastatic Castration-resistant Prostate Cancer.
Clin Cancer Res
2
2023
Author NameAffiliation
Anthony M JoshuaKinghorn Cancer Centre, Saint Vincent's Hospital
Adrian L Harris
  • 1 - 2

Datasets

Release 1.2